Quantcast
Connect with us

Dana Rohrabacher pointedly did not deny a key allegation about his dealings with Assange: Ex-US Attorney

Published

on

In response to the report that he had offered WikiLeaks founder Julian Assange a pardon from President Donald Trump in return for denying Russia’s involvement in the hack of DNC emails, former Rep. Dana Rohrabacher (R-CA) put out a statement.

“At no time did I offer Julian Assange anything from the President because I had not spoken with the President about this issue at all,” read Rohrabacher’s statement. “However, when speaking with Julian Assange, I told him that if he could provide me information and evidence about who actually gave him the DNC emails, I would then call on President Trump to pardon him.”

ADVERTISEMENT

But as former U.S. Attorney Renato Mariotti noted on Twitter, this statement actually does not deny one the core allegation of the report:

Indeed, all Rohrabacher is really denying here is that Trump was in on the scheme to trade a pardon for a cover-up of Russian involvement — he is not denying that the scheme took place at all.

For the record, Rohrabacher’s denials that Trump was involved appear doubtful, given that in 2017 he openly suggested he was involved in a “confidential interaction” with the White House regarding Assange. But even if Trump indeed wasn’t behind the offer, what Rohrabacher is admitting is incredibly damning for his own actions.

ADVERTISEMENT


Report typos and corrections to: [email protected].
READ COMMENTS - JOIN THE DISCUSSION
Continue Reading

Breaking Banner

French hospital halts trials of Trump-promoted COVID-19 drug due to worries about heart failure

Published

on

President Donald Trump's promotion of hydroxychloroquine as a treatment for COVID-19 has drawn criticism from medical experts who say much more work needs to be done before anyone can say it's effective at stopping the disease.

And now one hospital in France has stopped its testing of hydroxychloroquine on COVID-19 patients over worries that the drug poses a "toxic risk" to people's hearts when taken in combination with other drugs.

French newspaper Nice Matin reports that Nice University Hospital "immediately stopped" its use of hydroxychloroquine in patients who exhibit "major risks" of suffering heart failure due to the drug.

Continue Reading

Breaking Banner

Economist who hoped for ‘V-shaped’ recovery now predicting a prolonged downturn even worse than the Great Recession

Published

on

Tim Bartik is among the economists who has described the type of “V-shaped” economic recovery he would like to see in the United States following the coronavirus pandemic. Ideally, Bartik has asserted, all the businesses that have been shut down by the pandemic would reopen quickly when it’s safe to do so and put millions of Americans back to work. But journalist Andy Balaskovitz, in an article published in MiBiz on April 8, explains why Bartik (a senior economist at the W.E. Upjohn Institute for Employment Research in Kalamazoo, Michigan) now believes that predictions of a “V-shaped recovery” are wishful thinking — and why Americans are in for a lot of economic pain in the months ahead.

Continue Reading
 

Breaking Banner

‘Recipe for disaster’: Officials in Florida city say they face ‘unimaginable’ potential death from COVID-19

Published

on

Officials in the Florida city of Hialeah are warning that they are uniquely vulnerable to the COVID-19 pandemic and face the possibility of "unimaginable" death from the disease.

In interviews with The Daily Beast, the officials explained how their large population of senior citizens is at grave risk if Hialeah erupts as a major COVID-19 hotspot.

"I think it is going to get a lot worse," Hialeah Councilman Jesus Tundidor tells The Daily Beast. “The experts have been telling us to expect a peak [in Florida] near the end of the month. As we get more testing sites up and running, the more positive cases we will see. And that will create more fear."

Continue Reading
 
 
You need honest news coverage. Help us deliver it. Join Raw Story Investigates for $1. Go ad-free.
close-image